Investing Outlook: Challenges and Opportunities in the Cannabis Industry



Date: June 13, 2017

Time: 7:30 a.m.—2:00 p.m.

Location: Langham Hotel, 250 Franklin St, Boston, MA 02110

Contact: Kristy Treacy
ktreacy@nixonpeabody.com
617-345-6126

We are pleased to present this complimentary roundtable discussion for private equity, venture capital and family office investors, corporate executives, and professional advisors exploring possible investment opportunities in the cannabis industry.

Following the roundtable discussion, our NP Capital Connector® program will provide a forum for investors and companies in the cannabis industry to meet and discuss possible investment opportunities. For information about the companies participating in the second part of the program, please click here.

Join industry leaders on Tuesday, June 13, for an interactive discussion about the latest trends, including:

  • What is the latest from D.C. on the illegality of cannabis under federal law?
  • What is state of investing in the Cannabis industry in Massachusetts?
  • What have investors in Washington and Colorado learned that can be applied to investing in Massachusetts?
  • When can we stop using greenbacks only and make deposits?
  • What hot products and services in the cannabis industry are trending in 2017?

Schedule

Part 1: Hot Topics Roundtable Program
7:30 a.m. Registration and networking
8:15–9:30 a.m.Roundtable discussion

Part 2: NP Capital Connector® Session
10:00 a.m.–12:30 p.m. Company presentations
Noon Networking lunch
12:30–2:00 p.m. Company presentations

Featured speakers

  • Shanel Lindsay , Founder & President, Ardent Cannabis
  • William Luzier, Political Director, Marijuana Policy Project
  • David Rheins, Founder and Executive Director, Marijuana Business Association
  • John Stroppa, Founder, Occidental Park
  • Roger Tilton, Founder/Director, full_tiltON ventures, llc

Our speakers

  • Philip Taub, Head of Private Equity & Investment Funds, Nixon Peabody LLP
  • Rudy Salo, Partner, Public Finance Group, Nixon Peabody LLP
Back to top